AcouSort AB (publ) (STO:ACOU)
2.960
-0.020 (-0.67%)
At close: Mar 27, 2026
AcouSort AB Market Cap
AcouSort AB has a market cap or net worth of 62.65 million as of March 27, 2026. Its market cap has increased by 14.92% in one year.
Market Cap
62.65M
Enterprise Value
56.35M
Revenue
10.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.96
Market Cap Chart
Since January 9, 2017, AcouSort AB's market cap has decreased from 65.36M to 62.65M, a decrease of -4.15%. That is a compound annual growth rate of -0.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 62.65M | 4.59% |
| Dec 30, 2025 | 59.89M | -63.54% |
| Dec 30, 2024 | 164.28M | -29.12% |
| Dec 29, 2023 | 231.76M | 18.13% |
| Dec 30, 2022 | 196.19M | -41.95% |
| Dec 30, 2021 | 337.98M | 24.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biovica International AB | 105.09M |
| Annexin Pharmaceuticals AB | 98.12M |
| Scandinavian ChemoTech AB | 96.73M |
| Alzinova AB | 91.12M |
| Biosergen AB | 85.01M |
| Magle Chemoswed Holding AB | 81.77M |
| OncoZenge AB | 78.67M |
| Pila Pharma AB | 69.35M |